Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC [Phase 2]
Phase 2 trial evaluating first-line pemetrexed plus cisplatin in patients with advanced non-squamous non-small cell lung cancer; the study w…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. [Phase 3]
A Phase 3 clinical trial is evaluating QL1706 in combination with platinum-containing chemotherapy as adjuvant therapy for stage II-IIIB non…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study [NA]
A multicenter randomized trial is comparing sublobar resection with lobectomy for small non-small cell lung cancers (2 cm or smaller) and is…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study to Evaluate D-1553 in Subjects With Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating D-1553 in non-small cell lung cancer has completed enrollment and the study status is listed as comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating D-1553 in combination therapy for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer [Phase 1, Phase 2]
Clinical trial update on tumor-infiltrating lymphocyte therapy combined with pembrolizumab for advanced or metastatic lung cancer (Phase 1/P…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: A Phase I Study of CFT8919 in Patients With Advanced NSCLC [Phase 1]
A Phase I clinical trial of CFT8919 in patients with advanced non-small cell lung cancer carrying EGFR mutations; the study status is not ye…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance [Phase 2]
A Phase 2 trial is evaluating maintenance therapy with a third-generation EGFR-TKI plus Anlotinib for non-small cell lung cancer with small …
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Improving Pulmonary Function Following Radiation Therapy [NA]
A completed clinical trial evaluating pulmonary function after radiation therapy in non-small cell lung cancer has posted results.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases [Phase 1]
A Phase 1 study evaluating the safety and mechanism of radium-223 dichloride in combination with pembrolizumab in stage IV non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of NGM831 as a monotherapy and in combination with pembrolizumab (with or without NGM438) in advanced or metastatic solid tu…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study comparing the amivantamab and lazertinib combination to osimertinib in locally advanced or metastatic non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing amivantamab plus lazertinib versus osimertinib in locally advanced or metastatic non-small cell lung cancer is activ…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis [Phase 2]
Phase 2 trial evaluating atezolizumab with carboplatin and pemetrexed in chemotherapy-naïve patients with asymptomatic brain metastases from…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial of pembrolizumab in metastatic non-squamous non-small cell lung cancer has completed, with results posted in October 2024.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC [Phase 1, Phase 2]
An early-phase clinical trial evaluating AK112 in combination with platinum-based chemotherapy for EGFR/ALK/ROS1-positive non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC [Phase 2]
A Phase 2 trial evaluating durvalumab as monotherapy or in combination with novel agents for unresectable Stage III non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors [Phase 1, Phase 2]
Phase I/II trial evaluating the safety and preliminary activity of nivolumab combined with vorolanib in patients with refractory thoracic tu…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects [Phase 3]
A Phase 3 trial evaluating pembrolizumab plus platinum-based chemotherapy with or without canakinumab in untreated locally advanced or metas…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
This clinical trial update reports results from a study assessing detection of circulating tumor cells in patients with non-small cell lung …
-
CLINICAL_TRIALS withdrawal · 2024-10-08Clinical Trial Update: Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating brigatinib after definitive chemoradiotherapy in ALK-rearranged stage III non-small cell lung cancer has been wit…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study [Phase 3]
This Phase 3 China-extension trial update reports completion and posting of results for the LEAP-006 study evaluating pemetrexed + platinum …
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer [Phase 1]
This update notes the completion of a Phase 1 trial evaluating stereotactic body radiation therapy for inoperable locally-advanced non-small…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study [NA]
An exploratory, completed clinical trial assessing the feasibility of a telecoaching physical activity intervention for patients with non-sm…